Answers are grounded in this paper and cite their sources.
Retrospective pilot study demonstrates viral suppression in high-risk HIV-1 patients, suggesting effective treatment.
ABT intensification effectively suppresses HIV-1 low-level viremia. Viral suppression reached 85.2% by week 28 in high-risk patients. CD4+ T-cell counts increased significantly without CD8+ expansion. The CD4/CD8 ratio improved markedly following ABT treatment.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: